Toshio Munesue
Overview
Explore the profile of Toshio Munesue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1445
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wakuda T, Benner S, Uemura Y, Nishimura T, Kojima M, Kuroda M, et al.
Brain Behav Immun
. 2024 Mar;
118:398-407.
PMID: 38461957
Although oxytocin may provide a novel therapeutics for the core features of autism spectrum disorder (ASD), previous results regarding the efficacy of repeated or higher dose oxytocin are controversial, and...
2.
Lo T, Kushima I, Kimura H, Aleksic B, Okada T, Kato H, et al.
Neuropsychopharmacol Rep
. 2023 Nov;
44(1):42-50.
PMID: 37915257
Aim: The present study aimed to examine the association between copy number variations (CNVs) in parkin (PRKN) and schizophrenia (SCZ) and autism spectrum disorder (ASD) in a large case-control sample....
3.
Kushima I, Nakatochi M, Aleksic B, Okada T, Kimura H, Kato H, et al.
Biol Psychiatry
. 2022 Jun;
92(5):362-374.
PMID: 35667888
Background: We aimed to determine the similarities and differences in the roles of genic and regulatory copy number variations (CNVs) in bipolar disorder (BD), schizophrenia (SCZ), and autism spectrum disorder...
4.
Kato Y, Kuwabara H, Okada T, Munesue T, Benner S, Kuroda M, et al.
Mol Autism
. 2021 Feb;
12(1):15.
PMID: 33622389
Background: Oxytocin is expected as a novel therapeutic agent for autism spectrum disorder (ASD) core symptoms. However, previous results on the efficacy of repeated administrations of oxytocin are controversial. Recently,...
5.
Yoshimura Y, Kikuchi M, Saito D, Hirosawa T, Takahashi T, Munesue T, et al.
Sci Rep
. 2020 Sep;
10(1):14558.
PMID: 32883965
Impairment in verbal communication abilities has been reported in autism spectrum disorder (ASD). Dysfunction of the serotonergic system has also been reported in ASD. However, it is still unknown how...
6.
Mahmuda N, Yokoyama S, Munesue T, Hayashi K, Yagi K, Tsuji C, et al.
Diseases
. 2020 Feb;
8(1).
PMID: 32046066
The transient receptor potential melastatin 2 (TRPM2) is a non-specific cation channel, resulting in Ca influx at warm temperatures from 34 °C to 47 °C, thus including the body temperature...
7.
Owada K, Okada T, Munesue T, Kuroda M, Fujioka T, Uno Y, et al.
Brain
. 2019 May;
142(7):2127-2136.
PMID: 31096266
Discrepancies in efficacy between single-dose and repeated administration of oxytocin for autism spectrum disorder have led researchers to hypothesize that time-course changes in efficacy are induced by repeated administrations of...
8.
Higashida H, Munesue T, Kosaka H, Yamasue H, Yokoyama S, Kikuchi M
Diseases
. 2019 Mar;
7(1).
PMID: 30813294
Approximately half of all autism spectrum disorder (ASD) individuals suffer from comorbid intellectual disabilities. Furthermore, the prevalence of epilepsy has been estimated to be 46% of patients with low intelligence...
9.
Munesue T, Minabe Y
Seishin Shinkeigaku Zasshi
. 2019 Jan;
118(6):399-409.
PMID: 30620499
The core symptoms of autism spectrum disorder (ASD) comprise impairments of social communication and social interactions as well as restricted and repetitive patterns of interests and activities. No definitive treatments...
10.
Yoshimura Y, Kikuchi M, Hiraishi H, Hasegawa C, Hirosawa T, Takahashi T, et al.
Psychiatry Res Neuroimaging
. 2018 Oct;
281:117-122.
PMID: 30292077
Autism spectrum disorders (ASDs) are neurodevelopmental conditions with impairments in social communication and interaction. Empathy is the ability to understand and share another person's inner life, and it is an...